Medifast (MED) Finished Goods (2011 - 2021)

Medifast's Finished Goods history runs 9 years deep, the most recent figure standing at $100.7 million for Q3 2021.

• Quarterly Finished Goods rose 387.59% year-over-year to $100.7 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $100.7 million (up 387.59% YoY) and the FY2020 annual result came in at $29.9 million, down 4.65% from the prior year.
• Finished Goods was $100.7 million for Q3 2021 at Medifast, up from $73.1 million in the prior quarter.
• Across five years, Finished Goods topped out at $100.7 million in Q3 2021 and bottomed at $10.5 million in Q3 2017.
• A 5-year average of $30.3 million and a median of $27.5 million in 2018 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2020 — Finished Goods sank 38.84% — and 2021, when it jumped 387.59%.
• Medifast's Finished Goods stood at $13.4 million in 2017, then soared by 90.27% to $25.5 million in 2018, then gained by 22.76% to $31.3 million in 2019, then fell by 4.65% to $29.9 million in 2020, then soared by 237.22% to $100.7 million in 2021.
• Business Quant data shows MED's Finished Goods at $100.7 million in Q3 2021, $73.1 million in Q2 2021, and $40.5 million in Q1 2021.